Samuel J Moed - Net Worth and Insider Trading
Samuel J Moed Net Worth
The estimated net worth of Samuel J Moed is at least $2 Million dollars as of 2024-11-13. Samuel J Moed is the SVP, Strat Plan & Analysis of Bristol-Myers Squibb Co and owns about 31,615 shares of Bristol-Myers Squibb Co (BMY) stock worth over $2 Million. Details can be seen in Samuel J Moed's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel J Moed has not made any transactions after 2015-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel J Moed
Samuel J Moed Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel J Moed owns 2 companies in total, including Bristol-Myers Squibb Co (BMY) , and Scinai Immunotherapeutics Ltd (SCNI) .
Click here to see the complete history of Samuel J Moed’s form 4 insider trades.
Insider Ownership Summary of Samuel J Moed
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2015-03-13 | SVP & Strat Plan & Analysis |
| SCNI | Scinai Immunotherapeutics Ltd | 2023-01-01 | director |
Samuel J Moed Latest Holdings Summary
Samuel J Moed currently owns a total of 1 stock. Samuel J Moed owns 31,615 shares of Bristol-Myers Squibb Co (BMY) as of March 13, 2015, with a value of $2 Million.
Latest Holdings of Samuel J Moed
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2015-03-13 | 31,615 | 59.02 | 1,865,917 |
Holding Weightings of Samuel J Moed
Samuel J Moed Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel J Moed has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 591 shares on March 13, 2015, which brought Samuel J Moed around $39,402.
Insider Trading History of Samuel J Moed
- 1
Samuel J Moed Trading Performance
Samuel J Moed Ownership Network
Ownership Network List of Samuel J Moed
Ownership Network Relation of Samuel J Moed
Samuel J Moed Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Samuel J Moed is the SVP & Strat Plan & Analysis of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Chief Commercial Officer Christopher S. Boerner , and EVP & Corporate Affairs Cari Gallman .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Samuel J Moed made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 5,071 shares made by Christopher S. Boerner , a net sale of 17,986 shares made by Ann Powell Judge , and a net purchase of 8,500 shares made by Samuels Theodore R. Ii .
In summary, during the past 3 months, insiders sold 700 shares of Bristol-Myers Squibb Co (BMY) in total and bought 1,830 shares, with a net purchase of 1,130 shares. During the past 18 months, 19,418 shares of Bristol-Myers Squibb Co (BMY) were sold and 15,401 shares were bought by its insiders, resulting in a net sale of 4,017 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Samuel J Moed Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel J Moed. You might contact Samuel J Moed via mailing address: Bristol-myers Squibb Company, Route 206 & Provinceline Road, Lawrenceville Nj 08543.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
